SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Ilya Sutskever rejected Meta’s bid for his $32B startup, so Zuckerberg is hiring his CEO instead

Iran targets Microsoft Be’er Sheva offices, damages residential complex

Weizmann Institute suffers over $500 million in damage from missile strike

"Increase your exposure to Israel. Long-term, that’s the right move"

Buzz

Most popular

Daily

Weekly

1

Ilya Sutskever rejected Meta’s bid for his $32B startup, so Zuckerberg is hiring his CEO instead

2

“Catastrophic loss”: Inside the destruction of Weizmann’s research labs

3

Weizmann Institute suffers over $500 million in damage from missile strike

4

Vibe coding fever: Solo entrepreneur’s Base44 acquired by Wix for $80 million

5

Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal

New Phase

2 stories about New Phase

Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.

09.06.24|Ariela Karmel

New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments

וידאו Ctech Mind the tech NY conference – Ofer Shalev

“We change cancer from a fatal disease to a chronic ailment”

Ofer Shalev, Founder & CEO at New Phase, spoke to CTech during Mind the Tech NY about New Phase and the technology behind the company